Angiogenic activity of an Onchocerca volvulus Ancylostoma secreted protein homologue

Molecular and Biochemical Parasitology

Volumn 129, Issue 1, 2003, Pages 61-68

  Higazi, Tarig B ^a   Pearlman, Eric ^b   Whikehart, David R ^c   Unnasch, Thomas R ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

CRISP; Filaria; Nematode; Neovascularization; River blindness

Indexed keywords

AMINO ACID; HELMINTH PROTEIN; HYBRID PROTEIN; MALTOSE BINDING PROTEIN; ONCHOCERCA VOLVULUS ANCYLOSTOMA SECRETED PROTEIN 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ESCHERICHIA COLI; GENE LOCUS; GENETIC CODE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRON; MICROFILARIA; MOLECULAR CLONING; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEOTIDE SEQUENCE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; OPEN READING FRAME; PARASITE; PARASITE ISOLATION; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SECRETION; QUALITATIVE ANALYSIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STIMULATION; STRAIN DIFFERENCE;

ANCYLOSTOMA; ESCHERICHIA COLI; FILARIA; ONCHOCERCA VOLVULUS;

EID: 0038173766     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(03)00094-X     Document Type: Article

References (27)

1. Hall L.R., Pearlman E. Pathogenesis of onchocercal keratitis (river blindness). Clin. Microbiol. Rev. 12:1999;445-453.
2. Chakravarti B., Lass J.H., Diaconu E., Bardenstein D.S., Roy C.E., Herring T.A.et al. Immune-mediated Onchocerca volvulus sclerosing keratitis in the mouse. Exp. Eye Res. 57:1993;21-27.
3. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr. Top. Microbiol. Immunol. 237:1999;1-30.
4. Liekens S., Clercq E.D., Neyts J. Angiogenesis: regulators and clinical application. Biochem. Pharmacol. 61:2001;253-270.
5. Salven P., Hattori K., Heissig B., Rfii S. Interleukin-1 alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J. 16:2002;1471-1473.
6. Zcharia E., Metzger S., Chajek-Shaul T., Friedmann Y., Pappo O., Aviv A.et al. Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis. J. Mammal Gland Biol. Neoplasia. 6:2001;311-322.
7. Tawe W., Pearlman E., Unnasch T.R., Lustigman S. Angiogenic activity of Onchocerca volvulus recombinant proteins similar to vespid venom antigen 5. Mol. Biochem. Parasitol. 109:2000;91-99.
8. Margalit H., Spouge J.L., Cornette J.L., Cease K.B., Delisi C., Berzofsky J.A. Prediction of immunodominant T cell antigenic sites from the primary sequence. J. Immunol. 138:1987;2213-2229.
9. HIBIO MacDNASIS Pro: DNA and protein sequence analysis systems. Hitachi Software Engineering Co., Ltd.; 1992.
10. Zagrod M.E., Whikehart D.R. Null effect of adenosine on cyclic nucleotides of the corneal endothelium: possible implications for adenosine-stimulated corneal deturgescence. Curr. Eye Res. 3:1984;293-298.
11. Dolbeare F., Beisker W., Pallavicini M., Vanderlaan M., Gray J. Cytochemistry for bromodeoxyuridine/DNA synthesis: stoichiometry and sensitivity. Cytometry. 6:1985;521-530.
12. Kenyon B.M., Voest E.E., Chen C.C., Flynn E., Folkman J., D'Amato R.J. A model of angiogenesis in the mouse cornea. Invest. Ophthalmol. Vis. Sci. 37:1996;1625-1632.
13. Dadzie K.Y., Remme J., Rolland A., Thylefors B. Ocular onchocerciasis and intensity of infection in the community. II. West African rainforest foci of the vector Simulium yahense. Trop. Med. Parasitol. 40:1989;348-354.
14. Remme J., Dadzie K.Y., Rolland A., Thylefors B. Ocular onchocerciasis and intensity of infection in the community. I. West African savannah. Trop. Med. Parasitol. 40:1989;340-447.
15. Unnasch TR, Meredith SEO. The use of degenerate primers in conjunction with strain and species oligonucleotides to classify Onchocerca volvulus. In: Clapp JP, editor. Species diagnostic protocols: PCR and other nucleic acid methods, vol. 50. Washington, DC: Humanae Press; 1996. p. 293-303.
16. Dadzie K.Y., Remme J., Baker R.H.A., Rolland A., Thylefors B. Ocular onchocerciasis and intensity of infection in the community. III. West African rainforest foci of the vector Simulium sanctipauli. Trop. Med. Parasitol. 41:1989;376-382.
17. Pearlman E. Experimental onchocercal keratitis. Parasitol. Today. 12:1996;261-267.
18. Imaizumi T., Itaya H., Nasu S., Yoshida H., Matsubara Y., Fujimoto K.et al. Expression of vascular endothelial growth factor in human umbilical vein endothelial cells stimulated with interleukin-1alpha - an autocrine regulation of angiogenesis and inflammatory reactions. Thromb. Haemost. 83:2000;949-955.
19. Saint Andre A., Blackwell N.M., Hall L.R., Hoerauf A., Brattig N.W., Volkmann L.et al. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science. 295:2002;1892-1895.
20. van Setten G.B. Vascular endothelial growth factor (VEGF) in normal corneal epithelium: detection and physiological importance. Acta Opthalmol. Scand. 75:1997;649-652.
21. Philipp W., Speicher L., Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest. Ophthamol. Vis. Sci. 41:2000;2514-2522.
22. Polverini P.J. The pathophysiology of angiogenesis. Crit. Rev. Oral Biol. Med. 6:1995;230-247.
23. Ma D., Tsai R., Chu W., Kao C., Chen J. Inhibition of vascular endothelial cell morphogenesis in culture by limbal epithelial cells. Invest. Ophthamol. Vis. Sci. 40:1999;1822-1828.
24. Yancopoulos G., Davis S., Gale N., Rudge J.S., Wiegand S., Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 407:2000;242-248.
25. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D.et al. Vessel cooption regression and growth in tumors mediated by angiopoietins and VEGF. Science. 284:1999;1994-1998.
26. Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I.et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5:1999;495-502.
27. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:2000;389-395.